Goldan Keith A.
Syndax Pharmaceuticals, Inc. · Chief Financial Officer
Goldan Keith A. is listed in filings as Chief Financial Officer at Syndax Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity and purchase activity. Recent filings connect the profile to Syndax Pharmaceuticals, Inc. (SNDX) and Abeona Therapeutics Inc. (ABEO). The current snapshot covers public activity from Jun 17, 2024 to Jun 2, 2026. Reported amounts are shown as $22.4K to $42.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $72k3.4k shares | SellFeb 9, 2026 | $21.03 | $22.71 | |
| $43k2.1k shares | SellFeb 6, 2026 | $20.62 | $22.71 | |
| $12k1.3k shares | SellJul 16, 2025 | $9.29 | $22.71 | |
| Disclosure amount unavailable3k shares | BuyMay 19, 2025 | -- | $22.71 | |
| $59k3.8k shares | SellFeb 10, 2025 | $15.50 | $22.71 | |
| $25k1.3k shares | BuyJun 14, 2024 | $20.03 | $22.71 |